China Everbright Limited (CEL), a cross-border investment and asset management firm, has announced the first close of its third healthcare fund after securing RMB 800 million ($115.2 million) in commitments from various investors.
CEL Healthcare Fund III is targeting to raise up to RMB 1.5 billion ($216 million) and will invest in healthcare services, medical instrument and equipment, innovative medicine, diagnostic reagents, and other areas of healthcare.
